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Abstract
Human herpesvirus 6 (HHV-6) is a widespread causative agent of exanthum subitum or roseola infantum. The15
species of HHV-6 is divided into two variants, HHV-6A and HHV 6-B, which might be detected and identified
by PCR and RE methods. The three samples of eye swabs from children with suspected HHV-6 neurological
illness were extracted by guanidium isothiocyanate method before running in PCR followed by agarose
electrophoresis as a detection stage. The positive results were then identified by RE analysis to determine the
variant of the viruses. One of the three samples (sample 2) shows positive result in direct electrophoresis and it20
was identified as HHV-6B which produced two fragments of 153bp and 70bp in the RE analysis. PCR and RE
analysis are useful methods in detection as well as identification of HHV-6.
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INTRODUCTION
Human herpesvirus 6 (HHV-6) is a widespread
causative agent of disease in the first 2 years of
life, namely exanthum subitum or roseola
infantum, characterized by high fever for a few30
days and appereance a rash coinciding with
subsidence of the fever (Yamanishi et al., 1988).
HHV- 6 infects almost 90% of people aged from
under 10 to 59 years without showing substantial
difference in the positive rate for all age group35
(Okuno et al., 1989). The virus was initially
isolated in 1986 from peripheral blood
lymphocytes (PBL) of patients with
lymphoproliverative disorders and immunes
abnormalities (Salahuddin et al., 1986). Electron40
microscope revealed HHV-6 is an enveloped virus,
and icosahedral symmetry with 162 capsomers
containing large double stranded DNA genome.
(Salahuddin et al., 1986, Joseph et al, 1986).
HHV-6 belongs to Roseolovirus genus of the -45
herpesvirus subfamily and the species of HHV-6 is
divided into two variants: HHV-6 variant A and B
(HHV-6A and HHV 6-B) (Ablashi et al., 1991).
This division is also supported by other studies
using monoclonal antibodies (Chandran et al.,50
1992), PCR amplification, and DNA hybridization
(Aubin et al., 1990). The two variants are closely
related but show consistent differences in
biological, immunological, epidemiological, and
molecular properties (Mori & Yamanishi, 2007).55
In order to detect HHV-6 infection, there are
some methods that might be approached by
serological methods as well as molecular methods.
Serological diagnosis is conducted by indirect
immunoflourescence for the presence of antibodies60
to HHV-6 (Irving & Anthony, 1990). On the other
hand, molecular methods for detection of HHV-6
can be conducted by PCR amplified by agarose gel
electrophoresis and dot blot hybridization with a
cloned DNA probe (Kondo et al., 1990).65
The aim of the paper is to give a brief
description of detection of HHV-6 infection and
identification of its variant in the communal and
clinical settings by means of PCR and restriction
endonuclease typing respectively.70
MATERIALS AND METHODS
DNA extraction
The extraction was conducted by guanidium75
isothiocyanate method. Three samples used in this
experiment were eye swabs in virus transport
medium from children with suspected HHV-6
neurological illness. In this stage, both infected
cells and distilled water would be extracted and80
purified as positive and negative control. For each
sample to be extracted 50l was added into a
sterile eppendorf tube contaning 200 l extraction
buffer (4M guanidinium isothiocyanate, 25 mM
sodium citrate, 0.5% (w/v) sarcosyl, 1mM85
dithiothreitol, and 62 g/cm3 glycogen) before it
was incubated at room temperature. After 10
minute incubation, 25l 3M sodium acetate was
36
added to each tube and mixed well. To each tube,
275l ice-cold iso-propanol was added and mixed
by inversion before it was incubated at room
temperature for 5 minutes. The sample was then
centrifuged at 12,000g for 10 minutes and the5
pellet was collected carefully. Having been added
with 550l ice-cold 70% ethanol, the sample was
centrifuged at 12,000g for 10 minutes. Afer
centrifugation, the pellet was collected carefully
and allowed to air dry for 5 minutes before it was10
dissolved in 50l sterile distilled water.
PCR and agarose gel electrophoresis
To prepare PCR reaction mixture, 50l 10x PCR15
buffer (1cm3 1M tris-HCl pH 8.3; 5 cm3 1M KCl;
200 l 1M MgCl2; 1 cm3 2% (w/v) gelatin and
2.8cm3 sterile distilled water stored at -20°C) was
added into a 1.5cm3 eppendorf tube. Other
components (10l deoxynucleotides, 5l primer20
H6-6, 5l primer H6-7, 277.5l sterile distilled
water, and 2.5l taq DNA polymerase GOLD
(Roche) were then added sequently. The tube was
then mixed well and dispensed into 45l  amount
in 0.2 cm3 tubes. After preparing PCR reaction25
mixture, 5l of DNA sample was added to a vial of
reaction mixture. Each tube and prepared extacted
DNA of HHV-6A and HHV-6B as control were
amplified in PCR machine (Perkin Elmer 9700)
with appropiate cycling programme (94°C/730
minutes; 50°C/30 seconds; and 70°C/30 seconds
for a cycle and 94°C/30 seconds; 50°C/30 seconds;
and 70°C/30 seconds for 40 cycles).
The oligonucleotides used as primers or probes
in PCR were designated H6-6 (5’-35
AAGCTTGCACAATGCCAAAAAACAG-3’
position 103133-103109 for variant A and 10426-
104242 for variant B) and H6-7 (5’-
CTCGAGTATGCCGAGACCCCTAATC-3’
position 102911-102935 for variant A and 104047-40
104131 for variant B). Amplification using primers
H6-6 led to 223bp fragment, whereas primers H6-7
allowed 220bp fragment to be amplified.
Agarose gel electrophoresis was carried out by
E-gel® (invitrogen) method. To a 0.5ml eppendorf45
tube containing 10l sample, 1 l loading buffer
(10mM tris-HCl pH 7.5; 1mM EDTA; 0.005%
bromophenol blue) was added followed by adding
10l sterile distilled water. Onto a 2% E-gel, 20l
of each sample was loaded and 10l DNA50
molecular weight (Invitrogen) was loaded as well.
To all unsused wells,  20l sterile distilled water
was loaded before the gel was run for 15-30
minutes and visualised on a transluminator.
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Restriction endonuclease typing
In 0.5ml eppendorf tubes, three sets of
digestion mixtures were prepared. The first set
contained 5l amplicon, 2l RE buffer A, 1l
AvaII (Roche), and 12l sterile distiled water. The60
second set contained 5l amplicon, 2l RE buffer
H,1l HinfI (Roche), and 12l sterile distiled
water, whereas the final set contained 5l
amplicon, 2l RE buffer A, 2l RE buffer H, and
13l sterile distiled water. All tubes were then65
incubated at 37°C overnight. After incubation, 2l
loading buffer was added to all tubes before 10l
sample was loaded onto a 10cm3 of 8%
polyacrylamide gel (6.9 cm3 sterile distilled water,
2 cm3 acrylamide:bis acrylamide (37.5:1), 1 cm370
tris-borate-EDTA buffer, 9l TEMED, and 100l
10%(w/v) ammonium persulphate). To one well,
10l Hyperladder II (Bioline) as DNA molecular
weight marker was also loaded. After loading
samples and marker, the electrophoresis was75
carried out at 100V for 45 minute before it was
then stained with ethium bromide and visualised on
a transluminator so that variant of HHV-6 product
might be determined.
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RESULTS
Detection of HHV-6 infection in the samples
In this experiment, both extract positive and
negative control were extracted and purified as85
described above in order to ensure that there is no
distorsion during amplification in PCR. DNA of
HHV-6A and HHV-6B was also loaded to ensure
the specificity of the added primer in amplification.
From three samples assayed by PCR and direct90
electrophoresis, sample 2 shows the positive result
of HHV-6 infection due to the same fragment as
extract positive control, and both extracted DNA of
HHV-6A and HHV-6B accounting for 233bp
(Figure 1).95
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Restriction endonuclease typing
In determination of variants of HHV-6
product, HHV-6 variant A is cleavaged by AvaII
producing two fragments of 141 bp and 82 bp in
the electrophoresis gel, and HHV-6 variant B120
Fig 1. Separation of viral DNA by PCR and direct electrophoresis
gel (left) and the DNA molecular weight markers (right). A
specifically-amplified band for HHV-6 corresponds to 233 base-
pairs.
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cleavaged by HinfI produces two fragments: 153
bp and 70 bp.
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DISCUSSION20
PCR has been widely used in HHV-6 detection,
particularly in clinical samples. This method might
be approached to detect the HHV-6 DNA’s in
peripheral blood mononuclear cells (MNCs),
plasma, saliva and urine of the patients (Suga et25
al., 1995). As opposed to serological method , PCR
more reliable and spesific in detection of HHV-6
infection performed only 1 to 2 days rather than 5
to 14 days in serological method (Kondo et al.,
1990).30
In this experiment, HHV-6 infection has been
detected in sample 2 by PCR and in direct
electrophoresis showing positive signal in 233bp
fragment. It is worth noting that there is no any
fragments detected in the lane of extract negative35
control and distilled water indicating there is no
contamination during amplification in PCR.
Contamination is a major problems in
amplification that can lead to false-positive results.
According to Borts et al., (2004) false-positive40
results might be caused not only by general
contaminants such as reagents, laboratory
disposables, equipment, or the environment, but
also by sample-to-sample contamination as well as
leakage between samples on agarose gels). Non45
spesific products owing to suboptimal  assay
condition may also lead to false positive results.
In order to differentiate the variant of HHV-6,
namely HHV-6A and HHV-6B, restriction enzyme
digestion can be performed. By using EcoRI, SstII,50
SaiI, XbaI, HindIII, Schirmer et al. (1991)
differentiated two different classes of HHV-6. In
this experiment, AvaII and HinfI were used to
identify two variants of HHV-6. Based on the
detection result, sample 2 was carried out into RE55
analysis and it was identified as HHV-6B due to
the same restriction-fragment profile at 153bp and
70bp after digestion as HHV-6B positive control.
Although HHV-6A and HHV-6B are closely
related, these two variants are consistently diferent60
in biological and epidemiological features. The
genome of HHV-6A is 159,321 bp (Gompels et al.,
1995) as opposed to HHV-6B which is 161,144bp
(Domiguez et al., 1999). In terms of replication in
in specific transformed T-lymphocyte cell lines,65
HHV-6A propagates in the the T-cell line HSB-2,
whereas HHV-6B grows in in primary lymphocytes
and in the Molt-3 or MT-4–T cells line (Mori &
Yamanishi, 2007). Furhermore, there is no clear
disease has yet been associated with HHV-6A, but70
HHV-6B is obviously the major causative agent of
exanthem subitum (ES) (Yamanishi et al., 1988)
PCR assay and restriction enzyme analysis are
useful methods in detection as well as
identification HHV-6 in terms of their sensitivity75
and specificity. PCR assay might be helpful,
perticularly in the development of HHV-6 drugs
such as acyclovir and ganciclovir, which are
available for the treatment of another viruses,
namely HSV, VZV, and CMV infection (Kondo et80
al., 1990). Restriction endonuclease analysis, on
the other hand, might be also helpful in
determination of genetic polymorphism affecting
the pathogenicity and biological properties as well
as viral transmission between two strains of the85
same HHV-6 species (Aubin et al., 1991).
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